Sinaptica Therapeutics

📍 Cambridge, United States🗓 Founded 2021👥 19 employees💰 Last funded Jan 2026
Medical Equipment Manufacturing🌐 sinapticatx.com
Website LinkedIn
Sinaptica Therapeutics™ is a Cambridge MA-based, clinical-stage company that has developed a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease (AD). The company was founded by two top clinical researchers in the field of noninvasive brain modulation for neurodegenerative disorders, together with support from biotech, digital health, and medical device industry executives. The company’s SinaptiStim™ System represents a totally new approach to treating AD by enhancing neuroplasticity via neurostimulation of key brain networks involved in memory, and has been granted FDA Breakthrough Designation based on unprecedented published Phase 2 sham-controlled data that achieved statistical significance on all four gold-standard cognitive & functional clinical endpoints. Sinaptica is building upon over a decade of research on innovative brain targeting methods, biophysical modeling, and noninvasive treatment protocols leveraging machine learning on proprietary datasets to create a foundational leap in personalized precision electromagnetic therapeutics. Based on highly significant published sham-controlled data, the companys neurostimulation device and integrated personalization engine has the potential to become one of the most clinically-effective treatments to reach Alzheimer’s patients in over two decades, and is protected by multiple pending patents.
5
Total investors
0
Early stage
5
Mid stage
0
Late stage
2021
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
2
Finland
2
Singapore
1
Investor activity2024–2026 · investors recorded per year
202412025320261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sinaptica Therapeutics?
Sinaptica Therapeutics has 5 investors on record on gritt.io, 5 mid-stage.
When did Sinaptica Therapeutics last raise funding?
The most recent investment in Sinaptica Therapeutics recorded on gritt.io was in January 2026.
When was Sinaptica Therapeutics founded?
Sinaptica Therapeutics was founded in 2021.
What industry is Sinaptica Therapeutics in?
Sinaptica Therapeutics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sinaptica Therapeutics based?
Sinaptica Therapeutics is headquartered in Cambridge, United States.